KF-111

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameKF-111
Drug Alias NameKF-111
ClassificationCell and gene therapy > Gene therapySmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAkeso Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkeso Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A